In addition to the novel CAR-T therapies offered through our clinical trials program, our care team can provide our patients two FDA-approved therapies:

Kymriah for acute lymphoblastic leukemia or non-Hodgkin lymphoma

Yescarta for non-Hodgkin lymphoma


Want to learn more about CAR-T clinical trials at UNC Lineberger?

Contact Us